Comparison of Bleeding Risk between Rivaroxaban and Apixaban: a Pilot Feasibility Study

Autor: Castellucci, Lana A, Hogg, Kerstin *, Chiang, Philip *, Wu, Cynthia M. *, Le Templier, Genevieve *, Le Gal, Gregoire, Rodger, Marc *
Zdroj: In Blood 8 December 2017 130 Supplement 1:1108-1108
Databáze: ScienceDirect